← Back to Clinical Trials
Recruiting NCT06934577

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Eye Diseases
Sponsor University of Michigan
Study Type INTERVENTIONAL
Phase N/A
Enrollment 900
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-12-04
Completion 2030-08
Interventions
Standard optometric examinationTechnology enhanced eye disease detection protocol

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.

Eligibility Criteria

Inclusion Criteria: • Speak English, Spanish, Arabic, Chinese, French, Hindi, Finnish, Albanian, Russian or Tagalog Exclusion Criteria: * significant eye pain * sudden decrease in vision within one week * binocular diplopia * cognitive impairment * pregnancy * previously declined participation

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE EYE DISEASES TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}